Topic: AS08-Treatment/AS08a-Current treatment options - Hypomethylating agents: PROLONGED SURVIVAL OBSERVED IN 133 MDS PATIENTS TREATED WITH ORAL DECITABINE/CEDAZURIDINE. (September 2021) - Savona, M.; Mccloskey, J.; Griffiths, E.; Yee, K.; Al-Kali, A.; Zeidan, A.M.; Deeg, H.J.; Patel, P.; Sabloff, M.; Keating, M.-M.; Dao, K.-H.; Zhu, N.; et al.